IL17B

IGSF2 (Immunoglobulin Superfamily Member 2), also known as CD101, is a protein encoded by the IGSF2 gene in humans. This protein is a member of the immunoglobulin superfamily, which is characterized by the presence of immunoglobulin-like domains.

Structure

IGSF2 is a type I transmembrane protein that contains multiple immunoglobulin-like domains. These domains are involved in protein-protein interactions and are crucial for the protein's role in the immune system. The extracellular region of IGSF2 is composed of several Ig-like domains, which are typical of proteins involved in cell adhesion and immune response.

Function

IGSF2 plays a significant role in the immune system. It is expressed on the surface of various immune cells, including T cells, B cells, and dendritic cells. The protein is involved in the regulation of immune responses, particularly in the modulation of T cell activation and proliferation. IGSF2 has been implicated in the suppression of T cell responses, which suggests a role in maintaining immune homeostasis and preventing autoimmunity.

Clinical Significance

Alterations in the expression or function of IGSF2 have been associated with various immune-related disorders. For instance, changes in IGSF2 expression have been observed in autoimmune diseases, where the regulation of T cell activity is disrupted. Additionally, IGSF2 may play a role in the immune evasion mechanisms of certain cancers, where its expression can influence the tumor microenvironment and immune surveillance.

Research Directions

Current research on IGSF2 is focused on understanding its precise role in immune regulation and its potential as a therapeutic target. Studies are exploring how modulation of IGSF2 activity could be used to enhance immune responses against tumors or to suppress unwanted immune activity in autoimmune diseases.

Also see

• Immunoglobulin superfamily
• T cell activation
• Autoimmune disease
• Immune system